CinnaGen Initiates a Phase 3 Clinical Trial of Vaxine’s COVID-19 Vaccine Technology

  On August 07, 2021, the first volunteer enrolled in the Phase 3 clinical study of Cinnagen’s COVID-19 vaccine candidate in Iran. The study is a randomized, double-blind, placebo-controlled trial and will evaluate the efficacy and safety of the vaccine in 16,876 adult participants. Subjects receive two doses, 21 days apart, of either Spikogen vaccine or […]

Australian-made coronavirus vaccine COVAX-19 shows promise in clinical trials

Vaxine’s COVID-19 vaccine technology has progressed to the final stages of a human clinical trial, after strong preliminary results demonstrating its ability to prevent coronavirus infections in animal models. This highly effective protein-based vaccine can be manufactured on a large scale and remain stable in normal refrigerated conditions. Read this full article here:Australian-made coronavirus vaccine […]